Human Monkeypox Virus infection
DOI:
https://doi.org/10.35451/3jp6vr60Keywords:
Monkeypox, virus, infection, transmissionAbstract
Monkeypox is a zoonotic disease. First, this infection was found in animals but has been widespread in humans and become a pandemic all over the world including Indonesia with different case fatality rates caused by monkeypox infection among the countries. Some clinical features caused by monkeypox infection are similar to other infections caused by chicken pox and other viruses. Treating and preventing monkeypox infection need holistic management among medical personnel.
References
[1] M. Sohan, Mst. S. Akter, and M. R. Islam, “Expedition of monkeypox virus from Africa to rest of the world: What has made this old foe so powerful?,” Annals of Medicine & Surgery, vol. 82, Oct. 2022, doi: 10.1016/j.amsu.2022.104688.
[2] D. B. D. Giulio and P. B. Eckburg, “Human monkeypox: an emerging zoonosis”.
[3] S. Al-Gburi and Z. Namuq, “A Review of the Recent Monkeypox Outbreak in 2022,” 2022.
[4] “Monkeypox Virus in Nigeria: Infection Biology, Epidemiology, and Evolution,” viruses, vol. 12, doi: 10.3390/v12111257.
[5] N. Chen et al., “Virulence differences between monkeypox virus isolates from West Africa and the Congo basin,” Virology, vol. 340, no. 1, pp. 46–63, Sep. 2005, doi: 10.1016/j.virol.2005.05.030.
[6] E. M. Zardi and C. Chello, “Human Monkeypox—A Global Public Health Emergency,” IJERPH, vol. 19, no. 24, p. 16781, Dec. 2022, doi: 10.3390/ijerph192416781.
[7] Y. A. Tajudeen, H. J. Oladipo, A. O. Muili, and J. G. Ikebuaso, “Monkeypox: A review of a zoonotic disease of global public health concern,” Health Promot Perspect, vol. 13, no. 1, pp. 1–9, Apr. 2023, doi: 10.34172/hpp.2023.01.
[8] M. C. Martín-Delgado et al., “Monkeypox in humans: a new outbreak,” Rev Esp Quimioter, Jul. 2022, doi: 10.37201/req/059.2022.
[9] E. M. Bunge et al., “The changing epidemiology of human monkeypox—A potential threat? A systematic review,” PLoS Negl Trop Dis, vol. 16, no. 2, p. e0010141, Feb. 2022, doi: 10.1371/journal.pntd.0010141.
[10] Y.-S. Huang et al., “Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review,” Expert Review of Anti-infective Therapy, vol. 15, no. 9, pp. 873–892, Sep. 2017, doi: 10.1080/14787210.2017.1364991.
[11] A. L. Hughes, S. Irausquin, and R. Friedman, “The evolutionary biology of poxviruses,” Infection, Genetics and Evolution, vol. 10, no. 1, pp. 50–59, Jan. 2010, doi: 10.1016/j.meegid.2009.10.001.
[12] M. Ullah, Y. Li, K. Munib, and Z. Zhang, “Epidemiology, host range, and associated risk factors of monkeypox: an emerging global public health threat,” Front. Microbiol., vol. 14, p. 1160984, May 2023, doi: 10.3389/fmicb.2023.1160984.
[13] V. Costello et al., “Imported Monkeypox from International Traveler, Maryland, USA, 202,” Emerging Infectious Diseases, vol. 28, no. 5, 2022.
[14] J. Guarner, C. del Rio, and P. N. Malani, “Monkeypox in 2022—What Clinicians Need to Know,” JAMA, vol. 328, no. 2, p. 139, Jul. 2022, doi: 10.1001/jama.2022.10802.
[15] J. Quarleri, M. V. Delpino, and V. Galvan, “Monkeypox: considerations for the understanding and containment of the current outbreak in non-endemic countries,” GeroScience, vol. 44, no. 4, pp. 2095–2103, Aug. 2022, doi: 10.1007/s11357-022-00611-6.
[16] M. Sari and N. Hairunisa, “A REVIEW OF THE MONKEYPOX OUTBREAK IN INDONESIA IN 2022,” DMJ, vol. 11, no. 5, pp. 268–274, Sep. 2022, doi: 10.14710/dmj.v11i5.35895.
[17] A. Endo et al., “Heavy-tailed sexual contact networks and monkeypox epidemiology in the global outbreak, 2022,” Science, vol. 378, no. 6615, pp. 90–94, Oct. 2022, doi: 10.1126/science.add4507.
[18] N. Girometti et al., “Demographic and clinical characteristics of confirmed human monkeypox virus cases in individuals attending a sexual health centre in London, UK: an observational analysis,” The Lancet Infectious Diseases, vol. 22, no. 9, pp. 1321–1328, Sep. 2022, doi: 10.1016/S1473-3099(22)00411-X.
[19] L. Jia et al., “Cases of Monkeypox show highly-overlapping co-infection with HIV and syphilis,” Front. Public Health, vol. 11, p. 1276821, Jan. 2024, doi: 10.3389/fpubh.2023.1276821.
[20] E. J. Tarín-Vicente et al., “Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study,” The Lancet, vol. 400, no. 10353, pp. 661–669, Aug. 2022, doi: 10.1016/S0140-6736(22)01436-2.
[21] J. Iñigo Martínez et al., “Monkeypox outbreak predominantly affecting men who have sex with men, Madrid, Spain, 26 April to 16 June 2022,” Eurosurveillance, vol. 27, no. 27, Jul. 2022, doi: 10.2807/1560-7917.ES.2022.27.27.2200471.
[22] J. C. Riopelle, V. J. Munster, and J. R. Port, “Atypical and Unique Transmission of Monkeypox Virus during the 2022 Outbreak: An Overview of the Current State of Knowledge,” Viruses, vol. 14, no. 9, p. 2012, Sep. 2022, doi: 10.3390/v14092012.
[23] World Health Organization, “Multi-country monkeypox outbreak: situation update.” Jun. 27, 2022.
[24] T. Singhal, S. K. Kabra, and R. Lodha, “Monkeypox: A Review,” Indian J Pediatr, vol. 89, no. 10, pp. 955–960, Oct. 2022, doi: 10.1007/s12098-022-04348-0.
[25] A. M. McCollum and I. K. Damon, “Human Monkeypox,” Clinical Infectious Diseases, vol. 58, no. 2, pp. 260–267, Jan. 2014, doi: 10.1093/cid/cit703.
[26] N. Erez et al., “Diagnosis of Imported Monkeypox, Israel, 2018,” Emerg. Infect. Dis., vol. 25, no. 5, pp. 980–983, May 2019, doi: 10.3201/eid2505.190076.
[27] K. D. Reed et al., “The Detection of Monkeypox in Humans in the Western Hemisphere,” N Engl J Med, vol. 350, no. 4, pp. 342–350, Jan. 2004, doi: 10.1056/NEJMoa032299.
[28] Moore MJ, Rathish B, Zahra F., “Mpox (Monkeypox).” StatPearls [Internet}.
[29] A. Y. Cheema, O. J. Ogedegbe, M. Munir, G. Alugba, and T. K. Ojo, “Monkeypox: A Review of Clinical Features, Diagnosis, and Treatment,” Cureus, Jul. 2022, doi: 10.7759/cureus.26756.
[30] E. M. Beer and V. B. Rao, “A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy,” PLoS Negl Trop Dis, vol. 13, no. 10, p. e0007791, Oct. 2019, doi: 10.1371/journal.pntd.0007791.
[31] J. Lu et al., “Mpox (formerly monkeypox): pathogenesis, prevention, and treatment,” Sig Transduct Target Ther, vol. 8, no. 1, p. 458, Dec. 2023, doi: 10.1038/s41392-023-01675-2.
[32] J. Kaler, A. Hussain, G. Flores, S. Kheiri, and D. Desrosiers, “Monkeypox: A Comprehensive Review of Transmission, Pathogenesis, and Manifestation,” Cureus, Jul. 2022, doi: 10.7759/cureus.26531.
[33] A. I. Kabuga and M. E. El Zowalaty, “A review of the monkeypox virus and a recent outbreak of skin rash disease in Nigeria,” Journal of Medical Virology, vol. 91, no. 4, pp. 533–540, Apr. 2019, doi: 10.1002/jmv.25348.
[34] E. DeHaan et al., PEP to Prevent HIV Infection. Johns Hopkins University, 2022. Accessed: Apr. 17, 2023. [Online]. Available: https://www.ncbi.nlm.nih.gov/books/NBK562734/
[35] K. Brown and P. Leggat, “Human Monkeypox: Current State of Knowledge and Implications for the Future,” TropicalMed, vol. 1, no. 1, p. 8, Dec. 2016, doi: 10.3390/tropicalmed1010008.
[36] J. P. Thornhill et al., “Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022,” N Engl J Med, vol. 387, no. 8, pp. 679–691, Aug. 2022, doi: 10.1056/NEJMoa2207323.
[37] Z. Jezek, S. S. Marennikova, M. Mutumbo, J. H. Nakano, K. M. Paluku, and M. Szczeniowski, “Human Monkeypox: A Study of 2,510 Contacts of 214 Patients,” Journal of Infectious Diseases, vol. 154, no. 4, pp. 551–555, Oct. 1986, doi: 10.1093/infdis/154.4.551.
[38] A. Gessain, E. Nakoune, and Y. Yazdanpanah, “Monkeypox,” N Engl J Med, vol. 387, no. 19, pp. 1783–1793, Nov. 2022, doi: 10.1056/NEJMra2208860.
[39] U.S. Food and Drug Administration, “FDA approves drug to treat smallpox.” Jun. 04, 2021.
[40] C. L. Hutson et al., “Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model,” mSphere, vol. 6, no. 1, pp. e00927-20, Feb. 2021, doi: 10.1128/mSphere.00927-20.
[41] H. Adler et al., “Clinical features and management of human monkeypox: a retrospective observational study in the UK,” The Lancet Infectious Diseases, vol. 22, no. 8, pp. 1153–1162, Aug. 2022, doi: 10.1016/S1473-3099(22)00228-6.
[42] P. Dashraath, K. Nielsen-Saines, C. Mattar, D. Musso, P. Tambyah, and D. Baud, “Guidelines for pregnant individuals with monkeypox virus exposure,” The Lancet, vol. 400, no. 10345, pp. 21–22, Jul. 2022, doi: 10.1016/S0140-6736(22)01063-7.
[43] D. W. Grosenbach et al., “Oral Tecovirimat for the Treatment of Smallpox,” N Engl J Med, vol. 379, no. 1, pp. 44–53, Jul. 2018, doi: 10.1056/NEJMoa1705688.
[44] Y. Huang, L. Mu, and W. Wang, “Monkeypox: epidemiology, pathogenesis, treatment and prevention,” Sig Transduct Target Ther, vol. 7, no. 1, p. 373, Nov. 2022, doi: 10.1038/s41392-022-01215-4.
[45] A. Sherwat, J. T. Brooks, D. Birnkrant, and P. Kim, “Tecovirimat and the Treatment of Monkeypox — Past, Present, and Future Considerations,” N Engl J Med, vol. 387, no. 7, pp. 579–581, Aug. 2022, doi: 10.1056/NEJMp2210125.
[46] S. Khattak et al., “The monkeypox diagnosis, treatments and prevention: A review,” Front. Cell. Infect. Microbiol., vol. 12, p. 1088471, Feb. 2023, doi: 10.3389/fcimb.2022.1088471.
[47] M. A. Obeid, H. Amaw, A. Alshehri c, and A. Adesokan, “Monkeypox: Emerging virus of concern; antivirals and vaccines therapeutic options,” Microbial Pathogenesis, Sep. 2022, doi: 10.1016/j.micpath.2022.105799.
[48] J. G. Rizk, G. Lippi, B. M. Henry, D. N. Forthal, and Y. Rizk, “Prevention and Treatment of Monkeypox,” Drugs, vol. 82, no. 9, pp. 957–963, Jun. 2022, doi: 10.1007/s40265-022-01742-y.
[49] P. E. M. Fine, Z. Jezek, B. Grab, and H. Dixon, “The Transmission Potential of Monkeypox Virus in Human Populations,” Int J Epidemiol, vol. 17, no. 3, pp. 643–650, 1988, doi: 10.1093/ije/17.3.643.
[50] centers for disease control and prevention, “Get Both Doses of the Mpox Vaccine.”
[51] S. A. Meo, T. Al-Khlaiwi, Z. F. Aljofan, A. I. Alanazi, and A. S. Meo, “Public Perceptions of the Emerging Human Monkeypox Disease and Vaccination in Riyadh, Saudi Arabia: A Cross-Sectional Study,” Vaccines, vol. 10, no. 9, p. 1534, Sep. 2022, doi: 10.3390/vaccines10091534.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 junita br tarigan, Maulinda Putri, Sri Ulina Br. Purba, Franciscus Ginting
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright in each article is the property of the Author.
